stockportfolio.pro
Ligand Pharmaceuticals Incorporated Gross Profit 2009–2025
Ligand Pharmaceuticals Incorporated (LGND) annual gross profit by fiscal year, computed from SEC filings. Compound growth +15.3%/yr over 16 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | — | — | — |
| FY 2024 | — | — | — |
| FY 2023 | — | — | — |
| FY 2022 | — | — | — |
| FY 2021 | — | — | — |
| FY 2020 | — | — | — |
| FY 2019 | — | — | — |
| FY 2018 | $245.12M | 97.5% | +80.6% |
| FY 2017 | $135.74M | 96.2% | +31.3% |
| FY 2016 | $103.40M | 94.9% | +56.4% |
| FY 2015 | $66.11M | 91.9% | +19.3% |
| FY 2014 | $55.40M | 85.8% | +28.1% |
| FY 2013 | $43.24M | 88.3% | +55.6% |
| FY 2012 | $27.79M | 88.5% | +10.6% |
| FY 2011 | $25.13M | 83.7% | — |
| FY 2010 | — | — | — |
| FY 2009 | — | — | — |
Source: Ligand Pharmaceuticals Incorporated SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Ligand Pharmaceuticals Incorporated
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeLigand Pharmaceuticals Incorporated — frequently asked questions
What is Ligand Pharmaceuticals Incorporated's gross profit?
Ligand Pharmaceuticals Incorporated (LGND) reported gross profit of $245.12M for fiscal year 2018, per its SEC filings.
How has Ligand Pharmaceuticals Incorporated's gross profit changed over time?
Between fiscal 2009 and 2025, LGND's gross profit grew at roughly 15.3% per year (compound annual rate), from $25.13M to $245.12M.
Where does this data come from?
Figures are computed from Ligand Pharmaceuticals Incorporated's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.